Don't believe a small reduction in immunization matters?
- Universities of South Florida and Pittsburgh publish an online immunization simulator.
- The simulator shows the stunning effect of even small drops in vaccination rates.
- It's not just anti-vaxxers threatening community health. There are economic and geographical factors as well.
Anxiety does not help other medical conditions, adding trouble on top of trouble.
- More than 137 million people in the United States are struggling to pay their medical bills, according to new research.
- A recent survey also suggests that employer-based insurance programs are not helping as much as believed.
- The worst hit group is uninsured Americans, who struggle to keep up with mounting medical expenses.
Antibiotics are often the fastest and simplest way for doctors to help their patients. But with the threat of drug-resistant bacteria, how do we stop prescribing antibiotics?
It marks a major shift in the government's battle against the opioid crisis.
- The nation's sixth-largest drug distributor is facing criminal charges related to failing to report suspicious drug orders, among other things.
- It marks the first time a drug company has faced criminal charges for distributing opioids.
- Since 1997, nearly 222,000 Americans have died from prescription opioids, partly thanks to unethical doctors who abuse the system.
When these companies compete, in the current system, the people lose.
- When a company reaches the top of the ladder, they typically kick it away so that others cannot climb up on it. The aim? So that another company can't compete.
- When this happens in the pharmaceutical world, certain companies stay at the top of the ladder, through broadly-protected patents, at the cost of everyday people benefitting from increased competition.
- Since companies have worked out how to legally game the system, Amin argues we need to get rid of this "one size fits all" system, which treats product innovation — "tweaks" — the same as product invention.
SMARTER FASTER trademarks owned by The Big Think, Inc. All rights reserved.